Pharmaceutical Printed Literature Association
Trade Association
Based in IL
AI Overview
With $1.4M in lobbying spend across 27 quarterly filings, Pharmaceutical Printed Literature Association is a significant lobbying presence. They deploy 11 individual lobbyists Their lobbying covers 3 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $60K |
| 2019 | $100K |
| 2020 | $180K |
| 2021 | $200K |
| 2022 | $150K |
| 2023 | $220K |
| 2024 | $190K |
| 2025 | $300K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Defense
Promoting continued access to pharmaceutical printed packaging information.
Promotion of legislative language within H.R. 3164, the agriculture, Rural Development, Food and Drug Administration, and Related agencies appropriations Act, 2020, to eliminate funding to complete regulations that would create an e-labeling standard for pharmaceutical packaging information.
Promotion of legislative language within H.R. 2500, the National Defense Authorization Act of 2020, to ensure that prescription drugs made available to Department of Defense military treatment facilities include labels that are printed and physically accompany the package from which the drug is to be dispensed and such label provides adequate directions for use of such drug.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019 and monitoring H.R. 7614 the FY21 Labor-HHS-Education Appropriations Bill.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Educating offices about paper labeling in FDA appropriations.
Showing 8 of 11 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.